653 related articles for article (PubMed ID: 30646395)
1. Polyvascular Disease and Risk of Major Adverse Cardiovascular Events in Peripheral Artery Disease: A Secondary Analysis of the EUCLID Trial.
Gutierrez JA; Mulder H; Jones WS; Rockhold FW; Baumgartner I; Berger JS; Blomster JI; Fowkes FGR; Held P; Katona BG; Mahaffey KW; Norgren L; Hiatt WR; Patel MR
JAMA Netw Open; 2018 Nov; 1(7):e185239. PubMed ID: 30646395
[TBL] [Abstract][Full Text] [Related]
2. Ticagrelor versus clopidogrel in patients with symptomatic peripheral artery disease and prior coronary artery disease: Insights from the EUCLID trial.
Berger JS; Abramson BL; Lopes RD; Heizer G; Rockhold FW; Baumgartner I; Fowkes FGR; Held P; Katona BG; Norgren L; Jones WS; Millegård M; Blomster J; Reist C; Hiatt WR; Patel MR; Mahaffey KW
Vasc Med; 2018 Dec; 23(6):523-530. PubMed ID: 29992857
[TBL] [Abstract][Full Text] [Related]
3. Incidence, Characteristics, and Outcomes of Myocardial Infarction in Patients With Peripheral Artery Disease: Insights From the EUCLID Trial.
Olivier CB; Mulder H; Hiatt WR; Jones WS; Fowkes FGR; Rockhold FW; Berger JS; Baumgartner I; Held P; Katona BG; Norgren L; Blomster J; Patel MR; Mahaffey KW
JAMA Cardiol; 2019 Jan; 4(1):7-15. PubMed ID: 30540355
[TBL] [Abstract][Full Text] [Related]
4. Polyvascular disease and long-term cardiovascular outcomes in older patients with non-ST-segment-elevation myocardial infarction.
Subherwal S; Bhatt DL; Li S; Wang TY; Thomas L; Alexander KP; Patel MR; Ohman EM; Gibler WB; Peterson ED; Roe MT
Circ Cardiovasc Qual Outcomes; 2012 Jul; 5(4):541-9. PubMed ID: 22715460
[TBL] [Abstract][Full Text] [Related]
5. Chronic kidney disease and risk for cardiovascular and limb outcomes in patients with symptomatic peripheral artery disease: The EUCLID trial.
Hopley CW; Kavanagh S; Patel MR; Ostrom C; Baumgartner I; Berger JS; Blomster JI; Fowkes FGR; Jones WS; Katona BG; Mahaffey KW; Norgren L; Rockhold FW; Hiatt WR
Vasc Med; 2019 Oct; 24(5):422-430. PubMed ID: 31339474
[TBL] [Abstract][Full Text] [Related]
6. Total Cardiovascular and Limb Events and the Impact of Polyvascular Disease in Chronic Symptomatic Peripheral Artery Disease.
Szarek M; Hess C; Patel MR; Jones WS; Berger JS; Baumgartner I; Katona B; Mahaffey KW; Norgren L; Blomster J; Rockhold FW; Hsia J; Fowkes FGR; Bonaca MP
J Am Heart Assoc; 2022 Jun; 11(11):e025504. PubMed ID: 35621222
[TBL] [Abstract][Full Text] [Related]
7. Ticagrelor for Prevention of Ischemic Events After Myocardial Infarction in Patients With Peripheral Artery Disease.
Bonaca MP; Bhatt DL; Storey RF; Steg PG; Cohen M; Kuder J; Goodrich E; Nicolau JC; Parkhomenko A; López-Sendón J; Dellborg M; Dalby A; Špinar J; Aylward P; Corbalán R; Abola MTB; Jensen EC; Held P; Braunwald E; Sabatine MS
J Am Coll Cardiol; 2016 Jun; 67(23):2719-2728. PubMed ID: 27046162
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular and Limb Outcomes in Patients With Diabetes and Peripheral Artery Disease: The EUCLID Trial.
Low Wang CC; Blomster JI; Heizer G; Berger JS; Baumgartner I; Fowkes FGR; Held P; Katona BG; Norgren L; Jones WS; Lopes RD; Olin JW; Rockhold FW; Mahaffey KW; Patel MR; Hiatt WR;
J Am Coll Cardiol; 2018 Dec; 72(25):3274-3284. PubMed ID: 30573030
[TBL] [Abstract][Full Text] [Related]
9. Acute Limb Ischemia in Peripheral Artery Disease.
Hess CN; Huang Z; Patel MR; Baumgartner I; Berger JS; Blomster JI; Fowkes FGR; Held P; Jones WS; Katona B; Mahaffey KW; Norgren L; Rockhold FW; Hiatt WR
Circulation; 2019 Aug; 140(7):556-565. PubMed ID: 31238713
[TBL] [Abstract][Full Text] [Related]
10. Impact of Procedural Bleeding in Peripheral Artery Disease: An Analysis From EUCLID Trial.
Kansal A; Huang Z; Rockhold FW; Baumgartner I; Berger JS; Blomster JI; Fowkes FG; Katona B; Mahaffey KW; Norgren L; Hiatt WR; Patel MR; Jones WS
Circ Cardiovasc Interv; 2019 Oct; 12(10):e008069. PubMed ID: 31581789
[TBL] [Abstract][Full Text] [Related]
11. Ticagrelor Compared With Clopidogrel in Patients With Prior Lower Extremity Revascularization for Peripheral Artery Disease.
Jones WS; Baumgartner I; Hiatt WR; Heizer G; Conte MS; White CJ; Berger JS; Held P; Katona BG; Mahaffey KW; Norgren L; Blomster J; Millegård M; Reist C; Patel MR; Fowkes FG;
Circulation; 2017 Jan; 135(3):241-250. PubMed ID: 27840336
[TBL] [Abstract][Full Text] [Related]
12. Effect of vorapaxar on cardiovascular and limb outcomes in patients with peripheral artery disease with and without coronary artery disease: Analysis from the TRA 2°P-TIMI 50 trial.
Qamar A; Morrow DA; Creager MA; Scirica BM; Olin JW; Beckman JA; Murphy SA; Bonaca MP
Vasc Med; 2020 Apr; 25(2):124-132. PubMed ID: 32000630
[TBL] [Abstract][Full Text] [Related]
13. Design and rationale for the Effects of Ticagrelor and Clopidogrel in Patients with Peripheral Artery Disease (EUCLID) trial.
Berger JS; Katona BG; Jones WS; Patel MR; Norgren L; Baumgartner I; Blomster J; Mahaffey KW; Held P; Millegård M; Heizer G; Reist C; Fowkes FG; Hiatt WR
Am Heart J; 2016 May; 175():86-93. PubMed ID: 27179727
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular events in acute coronary syndrome patients with peripheral arterial disease treated with ticagrelor compared with clopidogrel: Data from the PLATO Trial.
Patel MR; Becker RC; Wojdyla DM; Emanuelsson H; Hiatt WR; Horrow J; Husted S; Mahaffey KW; Steg PG; Storey RF; Wallentin L; James SK
Eur J Prev Cardiol; 2015 Jun; 22(6):734-42. PubMed ID: 24830710
[TBL] [Abstract][Full Text] [Related]
15. Rivaroxaban and Aspirin in Peripheral Artery Disease Lower Extremity Revascularization: Impact of Concomitant Clopidogrel on Efficacy and Safety.
Hiatt WR; Bonaca MP; Patel MR; Nehler MR; Debus ES; Anand SS; Capell WH; Brackin T; Jaeger N; Hess CN; Pap AF; Berkowitz SD; Muehlhofer E; Haskell L; Brasil D; Madaric J; Sillesen H; Szalay D; Bauersachs R
Circulation; 2020 Dec; 142(23):2219-2230. PubMed ID: 33138628
[TBL] [Abstract][Full Text] [Related]
16. Major bleeding in patients with peripheral artery disease: Insights from the EUCLID trial.
Ward R; Huang Z; Rockhold FW; Baumgartner I; Berger JS; Blomster JI; Fowkes FGR; Katona BG; Mahaffey KW; Norgren L; Vemulapalli S; Povsic TJ; Mehta R; Hiatt WR; Patel MR; Jones WS
Am Heart J; 2020 Feb; 220():51-58. PubMed ID: 31783279
[TBL] [Abstract][Full Text] [Related]
17. Rivaroxaban and Aspirin in Patients With Symptomatic Lower Extremity Peripheral Artery Disease: A Subanalysis of the COMPASS Randomized Clinical Trial.
Kaplovitch E; Eikelboom JW; Dyal L; Aboyans V; Abola MT; Verhamme P; Avezum A; Fox KAA; Berkowitz SD; Bangdiwala SI; Yusuf S; Anand SS
JAMA Cardiol; 2021 Jan; 6(1):21-29. PubMed ID: 32997098
[TBL] [Abstract][Full Text] [Related]
18. Association of Heart Failure With Outcomes Among Patients With Peripheral Artery Disease: Insights From EUCLID.
Samsky MD; Hellkamp A; Hiatt WR; Fowkes FGR; Baumgartner I; Berger JS; Katona BG; Mahaffey KW; Norgren L; Blomster JI; Rockhold FW; DeVore AD; Patel MR; Jones WS
J Am Heart Assoc; 2021 Jun; 10(12):e018684. PubMed ID: 34056910
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of Patients with Critical Limb Ischaemia in the EUCLID Trial.
Norgren L; Patel MR; Hiatt WR; Wojdyla DM; Fowkes FGR; Baumgartner I; Mahaffey KW; Berger JS; Jones WS; Katona BG; Held P; Blomster JI; Rockhold FW; Björck M;
Eur J Vasc Endovasc Surg; 2018 Jan; 55(1):109-117. PubMed ID: 29273390
[TBL] [Abstract][Full Text] [Related]
20. Association of Chronic Obstructive Pulmonary Disease with Morbidity and Mortality in Patients with Peripheral Artery Disease: Insights from the EUCLID Trial.
Galani J; Mulder H; Rockhold FW; Weissler EH; Baumgartner I; Berger JS; Blomster JI; Fowkes FGR; Hiatt WR; Katona BG; Norgren L; Mahaffey KW; Quint JK; Patel MR; Jones WS
Int J Chron Obstruct Pulmon Dis; 2021; 16():841-851. PubMed ID: 33824584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
